Preclast 1000mg/1000mg Injection
Marketer
Premedium Pharmaceuticals Pvt Ltd
Salt Composition
Imipenem (1000mg) + Cilastatin (1000mg)
Overview Preclast 1000mg/1000mg Injection
Combiflox 1000mg/1000mg Injection is a dual-antibiotic formulation indicated for treating serious bacterial infections. This medication combats infectious microorganisms, preventing infection spread. Administration of Combiflox 1000mg/1000mg Injection must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire treatment course, regardless of symptom improvement. Commonly reported adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. Severe or persistent side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions manifesting as skin rashes, itching, swelling, or respiratory distress. Prior to commencing treatment, disclose all current medications and pre-existing health conditions to your physician. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption is discouraged due to the potential for increased drowsiness. While typically non-impairing, refrain from driving if drowsiness or dizziness occurs.
Uses of Preclast 1000mg/1000mg Injection
Life-threatening bacterial diseases
Major Benefits of Preclast 1000mg/1000mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Preclast 1000mg/1000mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Preclast 1000mg/1000mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Preclast 1000mg/1000mg Injection works:
Preclast, a 1000mg/1000mg injectable formulation, unites imipenem, a bacterial growth inhibitor, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Cilastatin safeguards imipenem from enzymatic degradation (by dehydropeptidase I), thus prolonging its therapeutic efficacy within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Preclast 1000mg/1000mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Preclast 1000mg/1000mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
The administration of Preclast 1000mg/1000mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
The injectable medication Preclast (1000mg/1000mg) can induce adverse reactions potentially impairing driving ability. Certain side effects, including hallucinations (visual, auditory, or sensory), may impact a patient's capacity to operate a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, administering Preclast 1000mg/1000mg Injection requires careful consideration. Dosage modification of Preclast 1000mg/1000mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Preclast 1000mg/1000mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Preclast 1000mg/1000mg Injection :
Omitting a scheduled dose of Preclast 1000mg/1000mg Injection necessitates contacting your physician.
Facts to Know About Preclast 1000mg/1000mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently